Page 4 - Tnbse Result News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tnbse result. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tnbse Result Today - Breaking & Trending Today

Short Interest in NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Drops By 53.9%

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 8,900 shares, a decrease of 53.9% from the October 15th total of 19,300 shares. Based on an average trading volume of 2,280,000 shares, the days-to-cover ratio […] ....

New York , United States , Corp Symetryx , First Manhattan Co , Neubase Therapeutics Inc , Royal Bank , Renaissance Technologies , Worth Venture Partners , Neubase Therapeutics , Get Free Report , Street Corp , Venture Partners , Base Therapeutics , Neubase Therapeutics Daily , Nasdaq Nbse ,

Nagaland board announces Class 8 and 9 phase-2 final exam dates; exams start on Nov 30

NBSE Exams 2023: The marks and results of phase 1 and phase 2 will be consolidated and they should be submitted to the board through the portal by December 18, 2023. ....

Nagaland Board Of School Education , Nagaland Board , School Education , Social Sciences , Cbse Class 8 Exams , Cbse Class 9 Exams , Bse Phase 2 Exams , Bse Class Phase 2 Exams 2023 , Agaland Board Phase 2 Exams , Agaland Phase 2 Final Exams 2023 ,

Nagaland Board Exams 2024: HSLC, HSSLC exam registration begins on October 3

Nagaland Board Exams 2024 registration for HSLC, HSSLC begins on October 3 at nbsenl.edu.in. ....

Nagaland Board Of School Education , Nagaland Board , School Education , Nagaland Board Exams , Board Exams , Nagaland Board Exams 2024 , Nbse Board Exma ,

Insider Selling: NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Major Shareholder Sells 74,852 Shares of Stock

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) major shareholder Corp Symetryx sold 74,852 shares of the business’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $1.80, for a total transaction of $134,733.60. Following the transaction, the insider now owns 605,149 shares in the company, valued […] ....

New York , United States , Worth Venture Partners , First Manhattan Co , Neubase Therapeutics Inc , Securities Exchange Commission , Royal Bank , Corp Symetryx , Renaissance Technologies , Neubase Therapeutics , Get Free Report , Exchange Commission , Base Therapeutics , Venture Partners , Street Corp , First Manhattan , Neubase Therapeutics Daily , Nasdaq Nbse , Insider Trading , Nsider Trades ,

FY2023 EPS Estimates for NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Raised by Analyst

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Free Report) – Equities researchers at Chardan Capital increased their FY2023 earnings per share estimates for shares of NeuBase Therapeutics in a research note issued to investors on Wednesday, August 16th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($5.19) for the […] ....

New York , United States , Worth Venture Partners , First Manhattan Co , Royal Bank , Renaissance Technologies , Neubase Therapeutics Inc , Neubase Therapeutics , Free Report , Chardan Capital , Neubase Therapeutic , Base Therapeutics , Venture Partners , Street Corp , First Manhattan , Get Free Report , Neubase Therapeutics Daily , Nasdaq Nbse , Earnings Estimates ,